Abstract:
The present invention relates to a biomarker for diagnosing age-related macular degeneration including vinculin protein, a kit for diagnosing age-related macular degeneration using the marker, a method for providing information necessary for the diagnosis, and a method for screening substance for treatment. The kit for diagnosing age-related macular degeneration and the diagnosing method, as a novel immunological diagnosing tool using blood plasma of a patient, can be usefully used in diagnosing age-related macular degeneration, and has excellent sensitivity and is capable of simply analyzing the blood plasma without using biopsy.
Abstract:
하기 화학식 1의 프탈라지논 유도체 또는 이의 약학적으로 허용 가능한 염은, 세로토닌 수용체 길항 작용과 세로토닌 재흡수 억제 작용을 동시에 지니고 있으므로, 이를 함유하는 약학적 조성물은, 우울증, 정신분열증, 불안증, 강박노이로제, 편두통, 식욕부진, 수면장애, 알츠하이머 병, 발작, 약물남용 등의 중추신경계에 관련된 질환 등의 치료제로서 유용하게 사용될 수 있다. [화학식 1]
Abstract:
PURPOSE: A new penam derivative using indium and zinc and a preparation method thereof are provided CONSTITUTION: A novel penam derivative represented by formula(I) is prepared by reacting 6-oxopenam of the formula(I') with ally halide of the formula (II) or acetylene halide of the formula (III) in the presence of indium or zinc. In the formula(I): R1 is allyl derivative and acetylene derivative; R2 is hydrogen, carboxylic acid salt(sodium salt and potassium salt as inorganic salt, alkyl amine salt, aromatic amine salt as organic salt) or carboxy protecting group(4-methoxy benzyl, diphenylmethyl, 4-nitrobenzyl, useful thing as protecting group of molecule in penicillin or cephalosporin compound field); R3 is hydrogen, halogen, hydroxy, acetoxy group.
Abstract translation:目的:提供一种新的使用铟和锌的青蒿衍生物及其制备方法。结构式(I)代表的新型青蒿衍生物通过使式(I')的6-氧代戊酸与式 II)或式(III)的乙炔卤化物在铟或锌存在下反应。 在式(I)中:R1是烯丙基衍生物和乙炔衍生物; R 2为氢,羧酸盐(作为无机盐的钠盐和钾盐,烷基胺盐,芳香胺盐作为有机盐)或羧基保护基(4-甲氧基苄基,二苯基甲基,4-硝基苄基,作为 分子在青霉素或头孢菌素化合物领域); R3是氢,卤素,羟基,乙酰氧基。
Abstract:
PURPOSE: Provided is a cephem derivative which has broad range of antimicrobial activity. And its producing method is also provided. CONSTITUTION: The cephalosporin compounds represented by formula (1) and its pharmaceutically acceptable salts are produced. In the formula, R1 is hydrogen or an amine protecting group generally used in cephalosporin compounds; R2 is hydrogen or an oxim protecting group; R3 is hydrogen or a chloro group; R5 is hydrogen or an ester producing group, a salt producing atom or a carboxy protecting group; and R4 is ring substituent having Q group, in which Q is hydrogen, halogen, hydroxy, mercapto, cyano, carboxy, carboxylic acid ester, carbamoyloxymethyl, N,N-dimethylcarbamoyloxymethyl, carbamoyl, N,N-dimethylcarbamoyl, C1 to C4 alkyl, C1 to C4 alkyloxy, halogen substituted methyl, halogen substituted C1 to C4 alkyloxy, aryl or hetero ring substituent. The cephalosporin derivative of formula (1) is produced by reacting a compound of formula (7) with a compound of formula (8).